Fabrx is a legitimate, highly innovative spin-out from UCL specializing in 3D-printed pharmaceuticals. However, the submission contains significant falsehoods: the claim 'most people have used my product' is incorrect (usage is limited to small clinical trials), and the audience reach is niche B2B, not 'everyone'. While the technology (M3DIMAKER) is cutting-edge and solves genuine medical problems (personalized dosage), the score is heavily penalized by the exaggerated and unreliable data provided in the submission. External verification confirms the company exists but is much smaller and earlier-stage than implied.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline